Authors: VANHECKEN A DEPRE M WYNANTS K ARNOUT J DOOSE D ABELS R VERCAMMEN E GIBSON D DESCHEPPER PJ

Citation: A. Vanhecken et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF RWJ-53308, A NONPEPTIDE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, IN HEALTHY-MEN/, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4732-4732

Authors: TRANCHESI B PILEGGI F VERCAMMEN E VANDEWERF F VERSTRAETE M

Citation: B. Tranchesi et al., RIDOGREL DOES NOT INCREASE THE SPEED AND RATE OF CORONARY RECANALIZATION IN PATIENTS WITH MYOCARDIAL-INFARCTION TREATED WITH ALTEPLASE AND HEPARIN, European heart journal, 15(5), 1994, pp. 660-664

Authors: VANDEWERF F SANTOPINTO J CORDERO FA FAINSTEIN D CORINALDESI A ZAVATTI D LUPPI O IPARRAGUIRRE HP HIRSCHSON A PIOMBO A LAPUENTE A KRITZER J SAMPO E AGINSKY R TAJER C CERCOS H BALLESTRINI A GUZMAN L MELE E BOND M THOMPSON A BAEFF O CORTEZ A RYBA D LOWENSTEIN J PENSA C ZAMUZ A LIMA RF MARMONTI M UBALDINI J LOPEZ JG BERRA FC YANGUAS M PALMA AL CASTILLA J CONCI E GAVIER MD BASTIANELLI R VERGOTTINI J BADARACCO R SANJURJO M SOSA C VENTURA A CARTASEGNA L ABALDE J TORRIJOS J PERRINO O ZOCCO J MONTENEGRO D CORSIGLIA D RIGHETTI L BADRA R GARCIA M ORTEGO R HIDALGO J ROMERO G RODENAS P ROSSI O PUCCINI V DIEZ A LOCATELLI H BRUERA E ROBIOLO A VILLARES J CUNEO C FALU E BECKER C MONGE A MINEN O CASANAS R FERNANDEZ R IBARZABAL U SIRENA J ALVAREZ A CASTELLANOS R MEULI M ROMERO M QUINTANA R SOUSA JEMR PIEGAS LS AVEZUM A TIMERMAN R ROMANO ER CARVALHO AC FAELLI D FARRAN J NICOLAU JC BRAGA J SILVA JAF BODANESE LC RIMENTEL P SANDOYA E LLUBERAS R AMARAL DC RODRIGUEZ JC DIAZ R PAOLASSO E VERCAMMEN E BROWER R FUSTER V MURRAY G TOPOL E WHITE H POLLOLA J PAVIOTTI C AIZPURUA M GONZALEZ N GUIRAO F RODRIGUEZ A SARMIENTO R LONDERO H SOUSA AGMR PINTO IM MOLTENI S SCHWARTZ H SZWARCER E CANALA M ESCALANTE L AGGIO M BARTOMIOLI M GIULIANI R MARELLO L VIDAL H ORLANDO S WOODS A NATTERO G VILLAFANE S LANARI E GUTNISKY E SAVARINO M DEKROLLE S DEPAOLETTI D MARCIPAR D HARRACA M MORALES M GENOVESI A BAITCH L SWING E MANRIQUE R

Citation: F. Vandewerf et al., RANDOMIZED TRIAL OF RIDOGREL, A COMBINED THROMBOXANE A(2) SYNTHASE INHIBITOR AND THROMBOXANE A(2) PROSTAGLANDIN ENDOPEROXIDE RECEPTOR ANTAGONIST, VERSUS ASPIRIN AS ADJUNCT TO THROMBOLYSIS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - THE RIDOGREL VERSUS ASPIRIN PATENCY TRIAL (RAPT)/, Circulation, 89(2), 1994, pp. 588-595

Authors: DECREE J GEUKENS H GUTWIRTH P DECLERCK F VERCAMMEN E VERHAEGEN H

Citation: J. Decree et al., THE EFFECT OF A COMBINED ADMINISTRATION OF RIDOGREL AND KETANSERIN INPATIENTS WITH INTERMITTENT CLAUDICATION, International angiology, 12(1), 1993, pp. 59-68